Entrectinib offers several advantages, particularly its ability to target multiple genetic alterations found in different types of cancer. This makes it a versatile treatment option for patients with molecularly targeted therapy needs. Additionally, its oral administration provides a convenient treatment form compared to traditional chemotherapy, which often requires intravenous delivery.
